Hepatitis C
Hepatitis C News


How lifestyle changes and food modification help to cure fatty liver
Chronic liver disease is mainly a lifestyle-related disease with a sedentary lifestyle being a predisposing factor


World Liver Day 2021: A few simple ways to keep your second-largest organ healthy
On World Liver Day, efforts are made to inform people about liver infections so that timely treatment from the preventable illness can be sought.


Hepatitis C drugs may inhibit main protease of SARS-CoV-2, aid in COVID-19 treatment, says study
As per the latest study, the stronger the binding efficiency of a compound with the enzyme, the better it would inhibit its activity.

Nobel Prize Medicine 2020 awarded to three researchers for discovery Hepatitis C virus, facilitating a cure
Discovery of the hepatitis C virus, the Nobel Committee said, had "made possible blood tests and new medicines that have saved millions of lives."


Blood, stool most common ways hepatitis viruses spread among humans; all you need to know
On World Hepatitis Day, observed every year on 28 July, let’s discuss the five main types of hepatitis viruses and the risk factors associated with each of them


World Hepatitis day 2020: Awareness key to prevent liver disease; B and C variants most common causes of death
The theme for World Hepatitis Day 2020 is 'Hepatitis-free future' with the main focus is on preventing hepatitis B among mothers and newborns.

World Hepatitis Day 2019: History, significance, this year's theme and objectives of global awareness campaign against deadly disease
Caused by different types of viruses, Hepatitis is of five types — Hepatitis A, B, C, D, and E. Among these, Hepatitis A, B, and C are the most common.

Patients accept kidneys infected with hepatitis C but stay uninfected themselves
In 2016, Johns Hopkins University launched a similar study with 10 people, all of who are now cured.

Hepatitis care in India: Country's awareness and prevention strategy is working but still has a long way to go
Hepatitis B is one of the leading causes of liver failure and liver cancer. Every 12th person in the world is infected.

Generic versions for Hepatitis C treatment cost-effective in terms of life expectancy: Study
About 71 million people are estimated to be affected with chronic Hepatitis C infection globally and of them six to 11 million are estimated to be in India

Lionel Messi takes a break from football to promote Hepatitis C charity event in Egypt
Argentinian football star Lionel Messi was in Egypt Tuesday as the face of an initiative to promote the North African country as a medical tourism destination for hepatitis C patients.

World AIDS Day: Beyond condoms, India must protect generic drug industry
India's war against HIV/AIDS shouldn't be limited to just awareness, but also with big pharma companies trying to overtake its generic drug industry, which is the only source of inexpensive medicine against the dreaded virus and diseases caused by it

World Hepatitis Day: Here is what you should know about the 'silent killer' disease
As 28 July is observed as World Hepatitis Day, here is what you should know about the 'silent killer' of a disease

Six Indian pharma companies get new licences to supply generic drugs
The UN-backed Medicines Patent Pool signed licences for the production of generic drugs.

Hepatitis C ups risk of head, neck cancers, finds new study
Individuals infected with Hepatitis C virus (HCV) may be prone to certain head and neck cancers, a new study has found

Combined HIV, hepatitis C vaccination a possibility soon, say researchers
Researchers have for the first time found it possible to generate simultaneous immune response against diseases such as Hepatitis C virus and HIV

Drug engineered from bananas could fight against AIDS, reveals new study
A substance found in bananas and carefully edited by scientists could lead to drugs that may fight off a wide range of deadly viruses, including AIDS.

Gilead to challenge hepatitis C drug patent rejection
An order by deputy controller of patents and designs Hardev Karar has said Gilead, which sells the drug under the Sovaldi brand in the US, failed to prove that there were enhancement of therapeutic efficacy in the new discovery.

In US, the latest treatment for Hepatitis C is a $1,000 pill
According to new research, prescriptions for Sovaldi have eclipsed all other hepatitis C pills combined in less than six months.

India has the second highest number of Hepatitis B infected patients
India has over 40 million Hepatitis B infected patients, second only to China, and most people with chronic Hepatitis B or C are unaware of their infection.